Shanghai's Smoking Rate down to 19.4%, E-cig Banned in Public No-smoking Areas

Market by 2FIRSTS.ai
Mar.07.2024
Shanghai's Smoking Rate down to 19.4%, E-cig Banned in Public No-smoking Areas
Shanghai smoking control legislation leads to 7.5% decrease in adult smoking rate, surpassing "Healthy China 2030" target ahead of schedule.

According to a report from China News Service, the adult smoking rate in Shanghai has decreased by 7.5% to 19.4% in the 15 years since the implementation of smoking control legislation, achieving the "Healthy China 2030" goal ahead of schedule. The Shanghai Health Promotion Center stated that since the comprehensive indoor smoking ban in 2017, the city's annual average enforcement penalty for smoking control has exceeded 2.2 million yuan, and the smoking situation in public places has continued to improve.

 

The Shanghai Municipal People's Congress Standing Committee passed an amendment to the "Regulations" in 2022, which includes e-cigarettes in the ban on smoking in public places, marking the advancement of "Smoke-Free Shanghai" into the 3.0 era. Currently, Shanghai is preparing to formulate the "Healthy Shanghai Action Plan (2019-2030)", defining the roadmap and tasks for tobacco control work, and gradually forming and improving the "Six Ones" management model for tobacco control promotion and law enforcement supervision.

 

In Shanghai, the concept and practice of "health integrating into all policies" has flourished in the field of tobacco control. For example, there are over 10,000 tobacco control volunteers in the city who conduct daily tobacco control propaganda and inspections across the city, effectively improving the precision law enforcement and supervision of tobacco control. Additionally, Shanghai has established 37 standardized smoking cessation clinics to provide professional smoking cessation services for smokers who want to quit.

 

In the future, the city will further establish a comprehensive Internet mobile smoking cessation platform, integrate all smoking cessation resources in the city, and create a more convenient and efficient integrated smoking cessation service network.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire’s FY2025 Q3 revenue fell 12.7% to $26.2 million, with net loss widening to $10.9 million. The company is shifting manufacturing to Malaysia, aiming to cut costs by $8 million annually, and has obtained a temporary nicotine production license. It also filed a blockchain-based PMTA component with the FDA and launched the Sprout™ cannabis device with Raw Garden to grow its presence in emerging markets.
May.13 by 2FIRSTS.ai
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
The U.S. International Trade Commission (ITC) has announced a partial review of a key ruling in PAX Labs' patent infringement case against STIIIZY and ALD, focusing on whether the economic prong of the "domestic industry" requirement was properly assessed. While the commission previously found some of PAX's patents valid and infringed, it ruled that PAX had not demonstrated sufficient U.S. economic investment to establish a domestic industry, and therefore did not find a violation.
May.20 by 2FIRSTS.ai
Australian opposition party proposes legalization of e-cigarette retail sales.
Australian opposition party proposes legalization of e-cigarette retail sales.
Australia's Coalition Pledges to Liberalize E-Cigarette Retail and Plans to Levy A$3.6 Billion in Taxes Over Four Years
May.06 by 2FIRSTS.ai
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA plans to fully integrate a generative AI system across its centers by June 30, 2025. This follows the successful completion of an initial pilot, marking a shift in the agency's approach to regulatory processes. The AI tools are expected to streamline the drug approval process, which typically takes six to ten months, by reducing time spent on repetitive tasks.
May.09 by 2FIRSTS.ai
Russia Proposes Using Tobacco License Fees to Fund COPD Treatment
Russia Proposes Using Tobacco License Fees to Fund COPD Treatment
Russia’s Democratic Forces have proposed using revenue from retail licenses for nicotine-containing products to fund treatment for chronic obstructive pulmonary disease (COPD).
May.19 by 2FIRSTS.ai
Insufficient Heating: Pain Point of Susceptor-Embedded HNB Smoking Article and Solutions thereof
Insufficient Heating: Pain Point of Susceptor-Embedded HNB Smoking Article and Solutions thereof
This article, contributed by patent attorney Ren Yongli to 2Firsts, analyzes the structural pain points of PMI's Terea sticks in electromagnetic heating and reviews technical solutions proposed by various industry players, including BAT, Shenzhen-based companies, and PMI’s own improvement strategies.
May.30